FDA Appoints Kathleen Uhl Acting Director for Office of Generic Drugs

A Food and Drug Administration official March 19 announced that Kathleen Uhl will serve as acting director of the Office of Generic Drugs (OGD), while the agency initiates a nationwide search for a permanent director.

The announcement was made in an email from Janet Woodcock, the director of FDA’s Center for Drug Evaluation and Research.

Uhl most recently served as the senior adviser to the director for OGD, Woodcock said.

Greg Geba, the former director of OGD, resigned from his position March 15 11 PLIR 335, 3/15/13.

“Dr. Uhl brings a wealth of regulatory and medical policy, scientific, and ...